2Clinical Collaborative Study Group of Low Molecular Weight Heparin (Correspondent: HU Dayi, XU Juntang. Beijing Red Cross Chaoyang Hospital, Beijing University of Medical Sciences, Beijing 100020, China).不稳定性心绞痛、急性非Q波心肌梗死不同抗栓疗法的对比研究[J].中华心血管病杂志,2000,28(1):18-21. 被引量：172
二级参考文献22
1Haas S,Schellong S.New anticoagulants:from bench to bedside[J].Hamostaseologie,2007,27(1):41-47.
2British Committee for Standards in Haematology.Guidelines on the use and monitoring of heparin[J].Br J Haematol,2006,133(1):19-34.
3Folwarczna J,Sliwinski L,Janiec W,et al.Effects of standard heparin and lowmolecular-weight heparins on the formation of murine osteoclasts in vitro[J].Pharmacol Rep,2005,57(5):635-645.
4Al Dieri R,Wagenvoord R,van Dedem GW,et al.The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif-the C-domain[J].J Thromb Haemost,2003,1(5):907-914.
5Hemker HC,al Dieri R,Wagenvoord R,et al.The Choay domain-the structure responsible for the anticoagulant action of heparins[J].Bull Acad Natl Med,2003,187(1):59-66.
7Favaloro EJ,Bonar R,Aboud M,et al.How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspective[J].Lab Hematol,2005,11(3):157-162.
8Lim W,Dentali F,Eikelboom JW,et al.Meta-analysis:low-molecular-weight heparin and bleeding in patients with severe renal insufficiency[J].Ann Intern Med,2006,144(9):673-684.
9White HD,Kleiman NS,Mahaffey KW,et al.Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutanoous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin,Revascularization and Glycoprotein Ⅱb/Ⅲa Inhibitors (SYNERGY) trial[J].Am Heart J,2006,152(6):1042-1050.
10Blazing MA,de Lemos JA,White HD,et al.Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin:a randomized controlled trial[J].JAMA,2004,292(1):55-64
